FindTrial
Sign In

Catheter Ablation Versus Antiarrhythmic Drugs for Outflow Tract Ventricular ARrhythmias

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01780311
Acronym
AVATAR
Enrollment
Unknown
Registered
2013-01-31
Start date
2013-01-31
Completion date
Unknown
Last updated
2013-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventricular Premature Complexes, Ventricular Tachycardia

Brief summary

A randomized, parallel, open study comparing catheter ablation versus antiarrhythmic drugs for outflow tract ventricular arrhythmias

Interventions

DRUGantiarrhythmic drugs (Flecainide or Propafenone or Sotalol)
PROCEDURECatheter Ablation

Sponsors

Ospedale San Donato
Lead SponsorOTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1\. presence of ventricular ectopic beats (VEB) with left-bundle-branch block morphology or right-bundle-branch block morphology and positive concordance throughout the chest leads, inferior axis and at least one of the following: 1. \>2000 isolated VEB/24h 2. symptomatic monomorphic ventricular tachycardia 3. left ventricular disfunction supposed to be due to tachycardia-induced cardiomyopathy

Exclusion criteria

1. known structural heart disease 2. pregnancy 3. life expectancy \< 1 year

Design outcomes

Primary

MeasureTime frameDescription
SF-36 score6 monthsQuality of life improvement according to SF-36 score variations

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026